From: SURF1 deficiency: a multi-centre natural history study
Laboratory or neuroimaging finding | Number of patients | % |
---|---|---|
Blood | Â | Â |
Metabolic acidosis | 21/33 | 64 |
Elevated lactate | 31/38 | 81 |
Cerebrospinal fluid | Â | Â |
Elevated lactate | 30/30 | 100 |
Muscle | Â | Â |
Reduced/absent COX histochemistry | 23/33 | 70 |
Type I fibre predominance | 8/33 | 24 |
Elevated muscle lipid content | 16/33 | 48 |
Reduced muscle COX activity | 25/26 | 96 |
Fibroblast | Â | Â |
Reduced fibroblast COX activity | 25/25 | 100 |
Nerve conduction studies | Â | Â |
Peripheral neuropathy | 13/16 | 81 |
MRI lesions | Â | Â |
Midbrain | 12/33 | 36 |
Pons | 10/33 | 30 |
Medulla | 15/33 | 45 |
Putamen | 16/33 | 48 |
Globus pallidus | 14/33 | 42 |
Caudate nucleus | 12/33 | 36 |
Subthalamic nucleus | 4/33 | 12 |
Periaqueductal grey matter | 4/33 | 12 |
Olivary nuclei | 3/33 | 9 |
Red nuclei | 2/33 | 6 |
Cerebellar white/grey matter | 6/33 | 18 |
Cerebellar atrophy | 3/33 | 9 |
Dentate nucleus | 13/33 | 39 |
Cerebellar peduncles | 8/33 | 24 |
Leukoencephalopathy | 2/33 | 6 |